For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

News

JCTO Group Photo

Clinical Trials Day 2022

Today is Clinical Trials Day. Together we represent unique perspectives across the entire clinical research continuum. From clinicians to contracts, and everything in between, it truly takes a team to conduct clinical trials and make a difference in our patients' lives. 

To help spread awareness, we’re sharing our messages on the importance of clinical trials and how we’re changing medicine at Weill Cornell Medicine and NewYork-Presbyterian Hospital. 

... Read More
image of a heart

Dr. Mario Gaudino Awarded Grant for STICH3C Study

A seven-year grant from the Canadian Institutes of Health Research will allow investigators from Weill Cornell Medicine and Sunnybrook Research Institute to compare the outcomes of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with low ejection fraction (EF). Known as STICH3C, this 750-patient study will be performed at 45 sites internationally through the Randomization...

Read More

Understanding Clinical Trials and How They Work

Clinical trials are vital to research, discovery and patient care at Weill Cornell Medicine and NewYork-Presbyterian. Here’s a rundown of how they work, whom they involve and what they accomplish. 

View information about clinical trials in Spanish (En Español).

Search our database to find a...

Read More
Dr. Roboz and AML Patient enrolled in clinical trial
Dr. Roboz and AML Patient Ralph Hills

Remission without Admission

In 2014, Ralph Hills was diagnosed with acute myeloid leukemia (AML) and his doctors told him to “get your affairs in order." Everything changed when he enrolled in an innovative clinical trial. Learn about the treatment that put his cancer into remission without requiring him to be admitted to the hospital.
Dr. Deborah Estrin Photo credit: John Abbott
Dr. Deborah Estrin Photo credit: John Abbott

There's an App for That

Last year, Apple unveiled a new platform that offers a streamlined way to create mobile applications linked to medical research. The technology, called ResearchKit, lets investigators more easily connect with the people whose diseases they're studying, allowing them to gather feedback on symptoms, as well as data on everything from a patient's weight to the air quality where they live. "When you can collect real-...

Read More
This image shows human embryonic stem cell-derived pancreatic beta cell clusters after being transplanted into immunodeficient mice. Image credit: Drs. Hui Zeng and Min Guo
This image shows human embryonic stem cell-derived pancreatic beta cell clusters after being transplanted into immunodeficient mice. Image credit: Drs. Hui Zeng and Min Guo

Researchers Develop Method to Identify Patient-Specific Drugs for Treating Diabetes

An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease. The research by Weill Cornell Medicine investigators was published Aug. 11 in Cell Stem Cell, and may extend the use of precision medicine to metabolic diseases.

Using...

Read More
Dr. Oliver Elemento
Dr. Oliver Elemento

We Are Weill Cornell Medicine: Dr. Olivier Elemento

Computational biologist Dr. Olivier Elemento was just 6 years old when he received his first microscope and computer. Now he is harnessing the power of both to spot patterns and trends in cancer that could help doctors treat the disease — and perhaps even find a cure.

"A lot of what we do involves taking patient samples and looking at what kind of mutations we...

Read More

Contact Information

Joint Clinical Trials Office Weill Cornell Medicine /
NewYork-Presbyterian
1300 York Avenue,
Box 305
New York, NY 10065 Phone: (646) 962-8215 Fax: (646) 962-0536

Abbreviation Library